Here are four things to know about the survey, which was launched in May:
- About 5 percent of survey participants reported spending more than $5,000 a month on cancer drugs. More than 10 percent reported spending between $1,000 and $4,999 a month.
- Nearly 20 percent of respondents or their family members have been living with cancer for more than 10 years.
- Approximately 35 percent of respondents said they receive financial support from an assistance program.
- Around 9 percent of participants reported being denied assistance.
More articles on cancer drugs:
Why this cancer drug is being fast-tracked for FDA approval
Protestors at ‘right to try’ rally in D.C. want access to experimental drugs
Novartis pledges to triple biosimilar drugs in market by 2020
